Purple biotech to present at the jefferies london healthcare conference

Rehovot, israel, nov. 03, 2021 (globe newswire) -- purple biotech ltd. ("purple biotech" ", or the "company") (nasdaq/tase: ppbt), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today announced that management will present a corporate overview at the jefferies london healthcare conference on wednesday, november 17, 2021 at 12:20 pm gmt. the conference will take place from november 16 - 19, 2021. management will be available for one-on-one meetings.
PPBT Ratings Summary
PPBT Quant Ranking